Enrolling in an Invasive Ductal Carcinoma Clinical Trial
An invasive ductal carcinoma clinical trial can provide a patient with a unique opportunity to be among the first people to benefit from a promising new breast cancer treatment that is not yet available in other settings. Through these important research studies, scientists and clinicians gain the information they need to determine whether new treatment options are more effective, or equally effective but produce fewer side effects, than the prevailing standard of care. If a treatment under evaluation in a clinical trial demonstrates better results than the treatment it is being compared to, the emerging treatment may become the new standard. In fact, all currently available treatment options were once available only through clinical trials.
With that said, a decision to participate in a breast cancer clinical trial should not be made lightly. After exploring all possible treatment options with a physician, a patient is encouraged to talk with family members and trusted friends. Ultimately, though, after gathering and reviewing all available information, only the patient can decide whether a specific trial is the right path to take.
Prior to enrolling in an invasive ductal carcinoma clinical trial, a patient should:
- Learn all about the trial, including its risks and benefits, what may happen and the costs involved, if any
- Understand the scope of informed consent (leaving the study at any time is always an option)
- Consider the extra time requirements (traveling to and from the study site, maintaining a log, etc.)
As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt Cancer Center is a recognized leader that continues to pave the way for breast cancer research. Through the groundbreaking clinical trials being performed in our Don & Erika Wallace Comprehensive Breast Program, our patients can potentially experience improved outcomes while making important contributions to the growing base of scientific knowledge, which can ultimately benefit all present and future breast cancer patients.
If you’d like to learn more about possibly participating in an invasive ductal carcinoma clinical trial, the experts at Moffitt can answer your questions and provide further information. Call 1-888-663-3488 or complete a new patient registration form online. No referrals are required.